Hot Keywords
Tumor Microenvironment Exosomes and Extracellular Vesicles Breast Cancer Metastasis Bone Metastasis Metastatic Renal Cell Carcinoma Lymph node metastasis Mesothelioma Hematological Malignancies Thyroid Cancer Liquid Biopsies Early Diagnosis Lung Cancer Brain Tumors Lymphoma Oncolytic Virus Cervical Cancer Cancer Stem Cells

The paper's citation list
No.The paper's citation list
1Iminodibenzyl induced redirected COX-2 activity inhibits breast cancer progression. 2021;7: doi: 10.1038/s41523-021-00330-9
2Obesity and endocrine therapy resistance in breast cancer: Mechanistic insights and perspectives. 2022;23: doi: 10.1111/obr.13358
3Ex vivo interaction between blood components and hormone-dependent breast cancer cells induces alterations associated with epithelial-mesenchymal transition and thrombosis. 2020;44:262 doi: 10.1080/01913123.2020.1749197
4Epithelial-to-Mesenchymal Transition Signaling Pathways Responsible for Breast Cancer Metastasis. 2022;15:1 doi: 10.1007/s12195-021-00694-9
5Breast cancer models: Engineering the tumor microenvironment. 2020;106:1 doi: 10.1016/j.actbio.2020.02.006
6EEF1A2 interacts with HSP90AB1 to promote lung adenocarcinoma metastasis via enhancing TGF-β/SMAD signalling. 2021;124:1301 doi: 10.1038/s41416-020-01250-4
7Hormone receptor expression in aging mammary tissue and carcinoma from a rodent model after xenoestrogen disruption. 2021;285:120010 doi: 10.1016/j.lfs.2021.120010
8The Potential for Natural Products to Overcome Cancer Drug Resistance by Modulation of Epithelial-Mesenchymal Transition. 2022;74:2686 doi: 10.1080/01635581.2021.2022169
9Two Novel Tri-Aryl Derivatives Attenuate the Invasion-Promoting Effects of Stromal Mesenchymal Stem Cells on Breast Cancer. 2019;19:1002 doi: 10.2174/1871520619666190212123912
10ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen. 2020;12:802 doi: 10.3390/cancers12040802
11Epithelial–Mesenchymal Transition Programs and Cancer Stem Cell Phenotypes: Mediators of Breast Cancer Therapy Resistance. 2020;18:1257 doi: 10.1158/1541-7786.MCR-20-0067
12Molecular Signatures of the Insulin-like Growth Factor 1-mediated Epithelial-Mesenchymal Transition in Breast, Lung and Gastric Cancers. 2018;19:2411 doi: 10.3390/ijms19082411
13Downregulation of CXXC Finger Protein 4 Leads to a Tamoxifen-resistant Phenotype in Breast Cancer Cells Through Activation of the Wnt/β-catenin Pathway. 2020;13:423 doi: 10.1016/j.tranon.2019.12.005
14Identification and Analysis of Estrogen Receptor α Promoting Tamoxifen Resistance-Related lncRNAs. 2020;2020:1 doi: 10.1155/2020/9031723
15The Role of Long Noncoding RNAs in Antiestrogen Resistance in Breast Cancer: An Overview and Update. 2020;23:129 doi: 10.4048/jbc.2020.23.e10
16Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells. 2019;8:642 doi: 10.3390/jcm8050642
17Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy. 2019;10: doi: 10.3389/fendo.2019.00245
18High glucose–induced Smad3 linker phosphorylation and CCN2 expression are inhibited by dapagliflozin in a diabetic tubule epithelial cell model. 2021;41: doi: 10.1042/BSR20203947
19Role of TGF-β signaling in the mechanisms of tamoxifen resistance. 2021;62:62 doi: 10.1016/j.cytogfr.2021.09.005
20Gene regulation gravitates toward either addition or multiplication when combining the effects of two signals. 2020;9: doi: 10.7554/eLife.59388
21Amyloid precursor protein promotes the migration and invasion of breast cancer cells by regulating the MAPK signaling pathway. 2019; doi: 10.3892/ijmm.2019.4404
22Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal Diseases by Estrogen Receptor Modulation and TGF-β1 Inhibition. 2020;21:4158 doi: 10.3390/ijms21114158
23Transforming growth factor alpha promotes tumorigenesis and regulates epithelial-mesenchymal transition modulation in colon cancer. 2018;506:901 doi: 10.1016/j.bbrc.2018.10.137
24miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB. 2019;9: doi: 10.1038/s41598-019-54289-6
25Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review). 2020; doi: 10.3892/ijo.2020.4990
26Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges. 2018;17: doi: 10.1186/s12943-018-0797-x
27Induced Tamoxifen Resistance is Mediated by Increased Methylation of E-Cadherin in Estrogen Receptor-Expressing Breast Cancer Cells. 2019;9: doi: 10.1038/s41598-019-50749-1
28Tracking Drug‐Induced Epithelial–Mesenchymal Transition in Breast Cancer by a Microfluidic Surface‐Enhanced Raman Spectroscopy Immunoassay. 2020;16:1905614 doi: 10.1002/smll.201905614
29Label-Free Proteomics Revealed Oxidative Stress and Inflammation as Factors That Enhance Chemoresistance in Luminal Breast Cancer. 2019;2019:1 doi: 10.1155/2019/5357649
30A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells. 2021;3: doi: 10.1093/narcan/zcab027
© 2016-2022 OAE Publishing Inc., except certain content provided by third parties